Pregabalin
Keywords:
pregabalin, gabapentinoid, antiepileptic drug
Abstract
Pregabalin is a newer generation gabapentinoid and is structurally similar to the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Gabapentin was initially synthesised over forty years ago as an adjuvant antiepileptic drug but has since become widely prescribed to treat neuropathic pain. Similarly, pregabalin use in epilepsy is limited and its use has been targeted for the treatment of neuropathic pain.1,2
Published
2022-05-03
Issue
Section
Reviews
By submitting manuscripts to SAPJ, authors of original articles are assigning copyright to Medpharm Publications (Pty) Ltd. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAPJ for educational and research purposes without obtaining permission.
